Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-05-24 Purchase |
2022-05-26 6:00 pm |
Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director |
4,500 | $1.29 | $5,805 | 9,006 (Direct) |
View |
2022-05-18 Purchase |
2022-05-20 6:15 pm |
Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer |
75,750 | $1.34 | $101,505 | 2,983,000 (Indirect Direct) |
View |
2022-05-18 Purchase |
2022-05-20 6:12 pm |
Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director |
4,479 | $1.3635 | $6,107 | 8,018 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-07-05 Option Award |
2024-07-10 4:10 pm |
N/A 2034-07-04 |
Virpax Pharmaceuticals Inc. | VRPX | Field Katharyn Director |
2,500 | $0 | 2,500 (Direct) |
View |
2024-07-05 Option Award |
2024-07-09 4:03 pm |
N/A 2034-07-04 |
Virpax Pharmaceuticals Inc. | VRPX | Herman Gary L Director |
2,500 | $0 | 2,500 (Direct) |
View |
2024-07-05 Option Award |
2024-07-09 4:02 pm |
N/A 2034-07-04 |
Virpax Pharmaceuticals Inc. | VRPX | Dhaliwal Jatinder Director |
2,500 | $0 | 2,500 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:26 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Singh Vanila Director |
25,000 | $0 | 25,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Shah Vinay Chief Financial Officer |
112,000 | $0 | 112,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Jambulingam Thani Director |
25,000 | $0 | 25,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:24 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Mathias Sheila Chief Scientific Officer |
112,000 | $0 | 112,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:23 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Dubin Michael F Director |
25,000 | $0 | 25,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:23 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director |
25,000 | $0 | 25,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:22 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Bruce Gerald W Chief Executive Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:22 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director |
45,000 | $0 | 45,000 (Direct) |
View |
2024-01-29 Option Award |
2024-01-31 4:21 pm |
N/A 2034-01-28 |
Virpax Pharmaceuticals Inc. | VRPX | Ruskin Barbara Director |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2023-10-03 09:51 am |
2022-04-07 2031-04-06 |
Virpax Pharmaceuticals Inc. | VRPX | Mathias Sheila Chief Scientific Officer |
0 | $0 | 197,676 (Direct) |
View |
2023-06-20 Option Award(A) |
2023-08-16 5:00 pm |
2024-06-20 2033-06-20 |
Virpax Pharmaceuticals Inc. | VRPX | Shah Vinay Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2023-06-20 Option Award |
2023-06-21 4:18 pm |
2024-06-20 2033-06-20 |
Virpax Pharmaceuticals Inc. | VRPX | Shah Vinay Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2023-04-24 Option Award |
2023-04-26 9:00 pm |
2023-04-24 2033-04-24 |
Virpax Pharmaceuticals Inc. | VRPX | Bruce Gerald W Director |
100,000 | $0 | 100,000 (Direct) |
View |
2023-03-24 Option Award |
2023-03-28 8:05 pm |
2024-03-24 2033-03-24 |
Virpax Pharmaceuticals Inc. | VRPX | Ruskin Barbara Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-01-25 Option Award(A) |
2023-02-07 9:30 pm |
N/A 2028-01-25 |
Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer 10% Owner |
125,000 | $0 | 125,000 (Direct) |
View |
2023-01-25 Option Award |
2023-01-27 8:30 pm |
N/A 2033-01-25 |
Virpax Pharmaceuticals Inc. | VRPX | Gudin Jeffrey Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2023-01-25 Option Award |
2023-01-27 8:30 pm |
N/A 2033-01-25 |
Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer 10% Owner |
125,000 | $0 | 125,000 (Direct) |
View |
2023-01-25 Option Award |
2023-01-27 8:30 pm |
N/A 2033-01-25 |
Virpax Pharmaceuticals Inc. | VRPX | Chipman Christopher Michael Chief Financial Officer |
112,000 | $0 | 112,000 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 8:30 pm |
2024-01-01 2033-01-01 |
Virpax Pharmaceuticals Inc. | VRPX | Jambulingam Thani Director |
40,000 | $0 | 40,000 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 8:30 pm |
2024-01-01 2033-01-01 |
Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director |
45,000 | $0 | 45,000 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 8:30 pm |
2024-01-01 2033-01-01 |
Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director |
35,000 | $0 | 35,000 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 8:30 pm |
2024-01-01 2033-01-01 |
Virpax Pharmaceuticals Inc. | VRPX | Dubin Michael F Director |
20,000 | $0 | 20,000 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 8:30 pm |
2024-01-01 2033-01-01 |
Virpax Pharmaceuticals Inc. | VRPX | Singh Vanila Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:00 pm |
2022-04-25 2032-04-25 |
Virpax Pharmaceuticals Inc. | VRPX | Bruce Gerald W Director |
60,000 | $0 | 60,000 (Direct) |
View |
2022-01-31 Option Award(A) |
2022-02-25 4:47 pm |
N/A 2032-01-31 |
Virpax Pharmaceuticals Inc. | VRPX | Gudin Jeffrey Chief Medical Officer |
60,676 | $0 | 60,676 (Direct) |
View |